Trial · NCT01757184
Participant flow32
How many started, completed or left each group, period by period.
1 to 20 of 32
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-blind Period | STARTED | Double-blind Sebelipase Alfa | 36 | |
| Double-blind Period | STARTED | Double-blind Placebo | 30 | |
| Double-blind Period | STARTED | Open-label Sebelipase Alfa/Sebelipase Alfa | 0 | |
| Double-blind Period | STARTED | Open-label Placebo/Sebelipase Alfa | 0 | |
| Double-blind Period | Received at Least 1 Dose of Study Drug | Double-blind Sebelipase Alfa | 36 | |
| Double-blind Period | Received at Least 1 Dose of Study Drug | Double-blind Placebo | 30 | |
| Double-blind Period | Received at Least 1 Dose of Study Drug | Open-label Sebelipase Alfa/Sebelipase Alfa | 0 | |
| Double-blind Period | Received at Least 1 Dose of Study Drug | Open-label Placebo/Sebelipase Alfa | 0 | |
| Double-blind Period | COMPLETED | Double-blind Sebelipase Alfa | 35 | |
| Double-blind Period | COMPLETED | Double-blind Placebo | 30 | |
| Double-blind Period | COMPLETED | Open-label Sebelipase Alfa/Sebelipase Alfa | 0 | |
| Double-blind Period | COMPLETED | Open-label Placebo/Sebelipase Alfa | 0 | |
| Double-blind Period | NOT COMPLETED | Double-blind Sebelipase Alfa | 1 | |
| Double-blind Period | NOT COMPLETED | Double-blind Placebo | 0 | |
| Double-blind Period | NOT COMPLETED | Open-label Sebelipase Alfa/Sebelipase Alfa | 0 | |
| Double-blind Period | NOT COMPLETED | Open-label Placebo/Sebelipase Alfa | 0 | |
| Open-label Period | STARTED | Double-blind Sebelipase Alfa | 0 | |
| Open-label Period | STARTED | Double-blind Placebo | 0 | |
| Open-label Period | STARTED | Open-label Sebelipase Alfa/Sebelipase Alfa | 36 | |
| Open-label Period | STARTED | Open-label Placebo/Sebelipase Alfa | 30 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01757184/flow